Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 1

Status

Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 1041Neoplasms 872Prostatic Neoplasms 506Lung Neoplasms 421Colorectal Neoplasms 357Motor Activity 219Head and Neck Neoplasms 194Uterine Cervical Neoplasms 189Carcinoma, Non-Small-Cell Lung 180Brain Neoplasms 173Pancreatic Neoplasms 160Ovarian Neoplasms 138Colonic Neoplasms 137Carcinoma, Hepatocellular 136Anxiety Disorders 124Rectal Neoplasms 117Hematologic Neoplasms 114Multiple Myeloma 106Stomach Neoplasms 103Neoplasm Metastasis 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 94Melanoma 92Depression 92Urinary Bladder Neoplasms 88Pain 87Endometrial Neoplasms 86Glioblastoma 84Disease 83Lymphoma 81Sarcoma 78

Interventions

Sevoflurane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Chalazion × 1 year × Clear all
NCT07450495 2026-03-04

SEVO-PED

Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong

Phase NA Recruiting
80 enrolled

Chalazion

NCT07405138 2026-02-19

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Not yet recruiting
40 enrolled

Chalazion

NCT07039461 2026-01-06

Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion

Lumenis Be Ltd.

Phase NA Terminated
4 enrolled

Chalazion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡